Literature DB >> 2778287

[Glanzmann's thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled cesarean section].

M Vivier1, A Treisser, M Naett, P Diemunsch, J P Schmitt, C Waller, M M Tongio, S Hemmendinger, P Lutz.   

Abstract

Glanzmann's thrombasthenia is a thrombopathy which affects primary hemostasis due to a qualitative or quantitative abnormality of membrane glycoproteins IIb-IIIa. The treatment of hemorrhages is usually associated with the transfusion of packed red blood cells and platelet concentrates. If massive allo-immunisation occurs, the transfusion will prove to be inefficient. A case of a cesarean section was scheduled after therapeutic plasmapheresis and platelet transfusions in a massively allo-immunised patient with Glanzmann's thrombasthenia. The plasma exchange made it possible to reduce to trace levels the concentrations of anti-PLA1 and anti-PLA2 antibodies, thus making platelet transfusions hemostatically efficient. The cesarean section was therefore safely performed when the bleeding time was normalized.

Entities:  

Mesh:

Year:  1989        PMID: 2778287

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  3 in total

1.  The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.

Authors:  Man-Chiu Poon; Roseline d'Oiron; Rainer B Zotz; Niels Bindslev; Matteo Nicola Dario Di Minno; Giovanni Di Minno
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

Review 2.  [Glanzmann's thrombasthenia and pregnancy: report of a case and literature review].

Authors:  Myriam Rachad; Hikmat Chaara; Fatim zahra Fdili; Sofia Jayi; Hakimat Bouguern; Moulay Abdelilah Melhouf
Journal:  Pan Afr Med J       Date:  2011-12-21

Review 3.  Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.

Authors:  Natalie Mathews; Georges-Etienne Rivard; Arnaud Bonnefoy
Journal:  J Blood Med       Date:  2021-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.